Concepedia
Author
L Li
Also Known As
2
Publications
725
Citations
H-Index
0
Concepts
All Affiliations
×
All Concepts
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
Bernard J. Komoroski, N. Vachharajani, L Li, +2
Clinical Pharmacology & Therapeutics
2009
383
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Bernard J. Komoroski, N. Vachharajani, David W. Boulton, +4
342
Page 1